People: AstraZeneca PLC (AZN.L)
18 Dec 2013
Dr. Briggs Morrison is the Executive Vice President - Global Medicines Development of AstraZeneca PLC., since January 2013 and leads the global late-stage development organisation for both small molecules and biologics. He joined AstraZeneca in 2012 from Pfizer, where he was Head of Medical Excellence, overseeing development, medical affairs, safety and regulatory affairs for Pfizer’s human health businesses. Briggs has a track record of developing novel medicines in roles at both Pfizer and Merck. Briggs has a biology degree from Georgetown University and a medical doctorate from the University of Connecticut. Briggs has also undertaken an internship and residency in internal medicine at the Massachusetts General Hospital, a fellowship in medical oncology at the Dana-Farber Cancer Institute and a post-doctoral research fellowship in genetics at Harvard Medical School.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|